Business Wire·May 15, 2026, 4:15 PM ET

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock granted inducement equity awards totaling 38,481 shares to six newly hired employees.
The awards consist of 12,061 inducement stock options & 26,420 inducement restricted stock units.
Awards are subject to the Company's 2022 Inducement Equity Plan, used exclusively for new hires or those returning after a non-employment period under Nasdaq Listing Rule 5635(c)(4).
Inducement stock options have an exercise price of $48.35, based on the closing price on May 11, 2026.
Stock options vest 25% on the first anniversary of the start date, with the remaining 75% vesting in 12 equal quarterly installments.
Restricted stock units vest in four equal annual installments.
All vesting is contingent upon the employees' continuing service through the applicable dates.
Scholar Rock is a late-stage biopharmaceutical company developing apitegromab for spinal muscular atrophy & other neuromuscular diseases.